IBO vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Sep 28, 2026

IBO

35.0
AI Score
VS
CLYM Wins

CLYM

45.4
AI Score

Investment Advisor Scores

IBO

35score
Recommendation
SELL

CLYM

45score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric IBO CLYM Winner
Net Income -11.84M -27.22M IBO
Operating Income -4.28M -30.57M IBO
ROE -96.2% -11.4% CLYM
ROA -68.0% -11.1% CLYM
Total Assets 17.41M 246.29M CLYM
Cash 3,000 44.11M CLYM
Current Ratio 0.35 31.45 CLYM

Relative Price Performance (Last 90 Days)

IBO 1M: +985.7% · 3M: +1015.3% CLYM 1M: -27.3% · 3M: -17.6%

Current Technical Phase

IBO

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (187.8% over 20 days), RSI 78

RSI (14): 78.1 · Price: $5.32

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 30

RSI (14): 30.3 · Price: $10.94

Fundamentals Snapshot

Metric IBO CLYM
Market Cap — —
Forward P/E 0.0 -10.9
Trailing P/E 0.5 —
Revenue (TTM) — —
Revenue Growth -0.6% 0.0%
Gross Margin -11.1% —
Operating Margin -234.0% 0.0%
EPS 11.11 -0.79
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 5 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.